类风湿性关节炎和心房动之间的关联:系统性审查和元分析
Vikash Jaiswal1, Poulami Roy2, Song Peng Ang3
1Department of Cardiovascular Research Larkin Community Hospital South Miami Florida USA.
Journal of arrhythmia
|April 8, 2024
概括
患有类风湿性关节炎 (RA) 的患者患上心房动 (AF),急性冠状动脉综合征 (ACS) 和全因死亡率 (ACM) 的风险显著增加. 这项研究强调了与RA相关的心血管风险增加.
科学领域:
- 类风湿病学 类风湿病学
- 心脏病学 心脏病学
- 流行病学 流行病学
背景情况:
- 类风湿性关节炎 (RA) 是一种全身性自身免疫性疾病,涉及多种器官,并可能导致不良健康结果.
- 关联RA和心房动 (AF) 并不确立,在现有文献中存在相互矛盾的证据.
- 了解RA患者的心血管风险对于全面的患者管理至关重要.
研究的目的:
- 系统地评估类风湿性关节炎 (RA) 和心房动 (AF) 之间的关联.
- 研究RA与其他主要临床结果之间的关系,包括急性冠状动脉综合征 (ACS),中风和全因死亡率 (ACM).
主要方法:
- 在PubMed,Embase和Scopus数据库中进行了系统的文献搜索.
- 来自相关文章的数据被聚合起来进行分析,包括总共4,679,930名患者 (81,677名RA患者).
- 主要结局是AF;次要结局包括ACS,中风和ACM.
主要成果:
- 患有RA的患者表现出明显更高的AF风险 (OR,1.53;95% CI: [1.16-2.03]).
- 关节炎患者的ACS (OR,1.39;95% CI: [1.26-1.52]) 和ACM (OR,1.19;95% CI: [1.03-1.37]) 的几率也显著增加.
- 在RA和非RA组之间没有观察到中风风险的显著差异 (OR,1.02;95%CI: [0.94-1.11]).
结论:
- 类风湿性关节炎与发展心房的风险显著增加有关.
- 关节炎患者面临急性冠状动脉综合征和全因死亡率的高风险.
- 这些发现强调了心血管风险评估和风险管理在风湿性关节炎患者中的重要性.
更多相关视频
08:10Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
1.7K
08:56Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
Published on: September 24, 2021
2.7K
相关概念视频
The JAK-STAT Signaling Pathway
8.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.8K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422
